Scientists warn that as an RNA virus, it possesses the natural ability to accumulate mutations over time—a process that could theoretically lead to strains capable of human-to-human transmission
A pandemic setting reminiscent of Covid is being staged globally following highly alarming statements regarding the evolution of the hantavirus, while it is confirmed that Moderna is preparing a vaccine. New statements by Alexander Ginsburg, the scientific director of the Gamaleya National Center of Epidemiology and Microbiology, regarding the evolution of the hantavirus and the virus's potential to acquire characteristics that could radically change its mode of transmission, are causing concern.
Ginsburg warned that hantavirus, as an RNA virus, has the natural ability to accumulate mutations over time—a process that could theoretically lead to strains capable of being transmitted from human to human. This statement is particularly significant because, to date, most hantaviruses are transmitted primarily through contact with infected rodents, droppings, or airborne particles from their environment. However, according to Alexander Ginsburg, the genetic nature of the virus leaves open the possibility of mutations appearing that could significantly increase its ability to survive and spread. "Hantavirus is an RNA virus, which means it accumulates various mutations, which can turn it into a virus that is transmitted from person to person," he stated characteristically.
Alexander Ginsburg
Capable of transmission over longer distances
This warning comes at a time when the global scientific community remains extremely sensitive to any potential threat of a new pandemic following the experience of COVID-19. RNA viruses are considered particularly unpredictable due to the high speed at which they mutate. This category includes other well-known viruses, such as coronavirus and influenza, which have proven in practice how quickly they can evolve and adapt.
Ginsburg explained that such mutations could offer hantavirus increased airborne resistance, allowing the virus to remain active for a longer period and be transmitted over longer distances. This is perhaps the most worrying element of his statement. To date, the limited airborne stability of hantavirus is one of the main reasons why its spread remains relatively controlled compared to other highly contagious viruses.
A dramatic evolution possible
If, however, strains with increased airborne resistance and the ability for human transmission appear in the future, then the data could change dramatically. Scientists clarify, however, that these statements concern a theoretical and evolutionary risk and are not proof that such a thing is already happening. Despite the concern caused by the possibility of mutations, there is currently no evidence that hantavirus has acquired a broad ability for human-to-human transmission on a global scale.
However, the history of epidemics has shown that viruses often evolve gradually and unpredictably. The experience of the COVID-19 pandemic has made international health authorities much more cautious toward warnings that might previously have been considered merely theoretical.
Mutations at the center
Hantavirus has been known for decades and is primarily associated with serious pulmonary and hemorrhagic complications. Some of its strains appear mainly in Asia and Europe, while others—such as the Andes virus—have been identified in South America. Scientific interest is now increasingly focused on monitoring the virus's genetic mutations and understanding whether it can evolve into more aggressive forms.
Ginsburg's statement also brings back to the forefront the discussion on global readiness for future health crises. Following the pandemic, many countries invested significant amounts in mRNA technologies, virus surveillance systems, and early warning programs. Experts emphasize that timely scientific monitoring of such viruses is critical precisely because mutations may appear gradually and only be noticed when transmissibility has already increased.
Global panic
At the same time, these statements fueled a new wave of concern and intense discussion on social media, where many users linked hantavirus to scenarios of a new pandemic. Scientists warn, however, that panic and misinformation can prove just as dangerous as the viruses themselves. Proper information, scientific surveillance, and calm risk assessment remain the basic tools for dealing with any potential health threat.
What is certain is that Alexander Ginsburg's statement serves as a reminder that the world continues to face constantly evolving biological risks. And in an era where travel and globalization accelerate the spread of diseases, even a virus that today is considered a limited threat could in the future turn into a serious international public health issue.
Moderna preparing a vaccine
At the same time, the fact that Moderna confirms it is already working on experimental vaccines for the virus, in collaboration with American military and academic bodies, is causing a sensation and raising questions. The development comes after a series of incidents that have drawn the attention of international media and health authorities, particularly following an outbreak of cases on a Dutch-flagged cruise ship off the Green Coast.
Against this backdrop, Moderna announced that it is already in the early stages of research for the development of vaccines against hantaviruses. The company is collaborating with the U.S. Army Medical Research Institute of Infectious Diseases, one of the most important American military biomedical research organizations, as well as the Vaccine Innovation Center of the Korea University College of Medicine.
This announcement caused intense movement in the markets and on social media, as several users linked the existence of research programs with recent hantavirus incidents. However, Moderna clarified that the relevant research had started long before the incident on the Hondius and is not a reaction to the current outbreak. "These efforts are at an early stage and are continuing as part of Moderna's broader responsibility to develop countermeasures against emerging infectious diseases," the company stated.
www.bankingnews.gr
Σχόλια αναγνωστών